Article
Precision medicine for Parkinson’s disease: The subtyping challenge
1 Dec 2022
Abstract excerpt
Despite many pharmacological and surgical treatments addressing the symptoms of Parkinson's disease, there are no approved treatments that slow disease progression. Genetic discoveries in the last 20 years have increased our understanding of the molecular contributors to Parkinson's pathophysiology, uncovered many druggable targets and pathways, and increased investment in treatments that might slow or stop the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
